These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6482577)

  • 21. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?
    Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG
    J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of rheumatoid arthritis using D-penicillamine].
    Ott VR; Schmidt KL
    Internist (Berl); 1974 Jun; 15(6):328-35. PubMed ID: 4211090
    [No Abstract]   [Full Text] [Related]  

  • 23. Lichenoid lesions of the oral mucosa in rheumatoid arthritis patients treated with penicillamine.
    Blasberg B; Dorey JL; Stein HB; Chalmers A; Conklin RJ
    J Rheumatol; 1984 Jun; 11(3):348-51. PubMed ID: 6737375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-related nephrotic syndrome in penicillamine-treated rheumatoid arthritis.
    Spiera H
    Mt Sinai J Med; 1984 Dec; 51(6):695-6. PubMed ID: 6335562
    [No Abstract]   [Full Text] [Related]  

  • 25. Penicillamine in rheumatoid arthritis: comparison of two dose schedules [proceedings].
    Hill AG; Hill HF
    Ann Rheum Dis; 1976 Dec; 35(6):541-2. PubMed ID: 1008625
    [No Abstract]   [Full Text] [Related]  

  • 26. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
    Munthe E; Kåss E
    J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fatal medullary aplasia after administration of D penicillamine for rheumatoid arthritis].
    Aymard JP; Baille N; Witz F; Colomb JN; Lederlin P
    Nouv Presse Med; 1980 Sep; 9(32):2255-6. PubMed ID: 7422520
    [No Abstract]   [Full Text] [Related]  

  • 28. Dose, plasma concentration and response relationships of D-penicillamine in patients with rheumatoid arthritis.
    Brooks PM; Miners JO; Smith K; Smith MD; Fearnley I; Birkett DJ
    J Rheumatol; 1984 Dec; 11(6):772-5. PubMed ID: 6520830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-penicillamine.
    Jaffe IA
    Bull Rheum Dis; 1977-1978; 28(6):948-52. PubMed ID: 630162
    [No Abstract]   [Full Text] [Related]  

  • 30. Diffuse fasciculations induced by D-penicillamine.
    Pinals RS
    J Rheumatol; 1983 Oct; 10(5):809-10. PubMed ID: 6644706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of common rheumatoid polyarthritis with D-penicillamine].
    Camus JP; Bénichou C; Guillien P; Crouzet J; Lièvre JA
    Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):809-20. PubMed ID: 5152714
    [No Abstract]   [Full Text] [Related]  

  • 32. [Side effects of D-penicillamine and pyritinol. Cooperative study among French hospital drug surveillance centers].
    Netter P; Tréchot P; Bannwarth B; Faure G; Royer RJ
    Therapie; 1985; 40(6):475-9. PubMed ID: 4089789
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis.
    Trice JM; Pinals RS; Plitman GI
    Arch Intern Med; 1983 Jul; 143(7):1487-8. PubMed ID: 6683487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic strategy in rheumatoid arthritis: a roundtable discussion.
    J Rheumatol Suppl; 1981; 7():124-45. PubMed ID: 6939875
    [No Abstract]   [Full Text] [Related]  

  • 35. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
    Capell HA; Hunter JA; Rennie JA; Murdoch RM
    J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penicillamine in the treatment of rheumatoid arthritis.
    Camp AV
    J Rheumatol Suppl; 1981; 7():103-6. PubMed ID: 6939871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myasthenia gravis as a complication of D-penicillamine therapy in rheumatoid arthritis.
    Wysocka K; Fabian F; Listewnik M
    Z Rheumatol; 1981; 40(3):135-7. PubMed ID: 7282112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [D-penicillamine--side effects, pathogenesis and decreasing the risks].
    Grasedyck K
    Z Rheumatol; 1988; 47 Suppl 1():17-9. PubMed ID: 3063003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term use of D-penicillamine in systemic scleroderma and rheumatoid arthritis].
    Guseva NG; Trofimova TM; Oskilko TG; Panasiuk AF; Tarasenkova TA
    Klin Med (Mosk); 1986 Jun; 64(6):44-50. PubMed ID: 3747436
    [No Abstract]   [Full Text] [Related]  

  • 40. [Animal experiments on the maintenance dose of D-penicillamine].
    Friedrich L; Wuppermann D; Zimmermann F
    Z Rheumatol; 1975; 34(9-10):309-13. PubMed ID: 812286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.